ArticleAmerican journal of respiratory and critical care medicine2025

Camlipixant in Refractory Chronic Cough: A Phase 2a, Randomized Controlled Trial (RELIEF).

Jaclyn A Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.